Neoadjuvant chemoradiotherapy before resection of perihilar cholangiocarcinoma: A systematic review.

[1]  J. Raftery,et al.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. , 2019, The Lancet. Oncology.

[2]  S. Maithel,et al.  Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Vauthey,et al.  Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. , 2018, The lancet. Gastroenterology & hepatology.

[4]  M. Matsumoto,et al.  Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma , 2018, World Journal of Surgery.

[5]  C. Moulton,et al.  Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada , 2018, Journal of surgical oncology.

[6]  G. Gores,et al.  Cholangiocarcinoma — evolving concepts and therapeutic strategies , 2018, Nature Reviews Clinical Oncology.

[7]  T. Teshima,et al.  A retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  D. Gouma,et al.  Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. , 2015, Journal of the American College of Surgeons.

[9]  J. Vauthey,et al.  Hilar cholangiocarcinoma: expert consensus statement. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[10]  David Goldstein,et al.  Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial , 2015 .

[11]  D. Nagorney,et al.  Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo Hilar Cholangiocarcinoma? , 2015, Journal of the American College of Surgeons.

[12]  E. Dixon,et al.  Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  M. Volk,et al.  Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  S. Jegatheeswaran,et al.  Contemporary management of perihilar cholangiocarcinoma in a nontransplant hepatopancreatobiliary center , 2013, European journal of gastroenterology & hepatology.

[15]  S. Curley,et al.  Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins , 2012, Journal of Gastrointestinal Surgery.

[16]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[17]  Johnny C. Hong,et al.  Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. , 2011, Archives of surgery.

[18]  R. Wolff,et al.  Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: A retrospective analysis. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. West,et al.  Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971–2001 , 2006, British Journal of Cancer.

[20]  G. Gores,et al.  Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma , 2005, Annals of surgery.

[21]  H. El‐Serag,et al.  The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.

[22]  G. Gores,et al.  Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma , 2004, Seminars in liver disease.

[23]  D. Gouma,et al.  Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[24]  S. Curley,et al.  Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. , 1997, American journal of surgery.

[25]  C. Willett,et al.  Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. , 2009, International journal of radiation oncology, biology, physics.